1 / 3
google
Article details
- Package size
- 10 x 3
- Selling units
- 30
- Measure
- Pflaster
- Galenic form
- Pflaster
- Galenic group
- Pflaster/Transdermale Systeme
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
TCPRA
|
0.45 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.16 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.036 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.041 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.81 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.08 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.08 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.49 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.068 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.044 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.0024 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.068 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.068 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.061 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.364 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.073 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.01 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.49 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.073 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.025 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.0008 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.025 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.015 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.016 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.015 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.0024 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.061 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.00081 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.034 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.034 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.081 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.054 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.49 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.054 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.07 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.0024 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.0041 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.07 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.041 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.065 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.2 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.15 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.97 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | WIZUS |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.011 MG | Substance | HBESI |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.011 MG | Substance | HBESI |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.16 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.16 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.02 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.02 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.16 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.02 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.16 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.16 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.0057 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.65 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.041 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.0055 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.0055 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.016 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.0055 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.0055 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
Authorization holder
Stallergenes AG
8305 Dietlikon
Authorization information
- Swissmedic authorization number
- 56688
- Drug name
- True Test, Pflaster
- Galenic form
- WIRSP
- ATC Code
- V04CL
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 29/09/2010
- Authorization expiration date
- 31/12/9999
- IT Number
- 14.03.0.
- Domain
- Human medicine
Package details
- Description (FR)
- TRUE TEST empl 10 x 3 pce
- Description (DE)
- TRUE TEST Pfl 10 x 3 Stk
- Market launch
- 26/07/2012
- Narcotic (BTM)
- No
Other package sizes (4)
None
10 PFLA
GTIN: None
None
None None
GTIN: None
None
None None
GTIN: None
TRUE TEST empl ancien 10 x 3 pce
None None
GTIN: 7680566880044